Foundation for Innovative New Diagnostics
Overview
Foundation for Innovative New Diagnostics is a global non-profit organization that drives innovation in the development and delivery of diagnostics to combat major diseases affecting the world's poorest populations.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cape Bio Pharms | Dec 2020 | Grant | Co-investor |
| Biomeme | Dec 2021 | VC Round | Lead |
| Cape Bio Pharms | Dec 2020 | Debt | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Foundation for Innovative New Diagnostics based?
Foundation for Innovative New Diagnostics is headquartered in Geneva, Switzerland.
When was Foundation for Innovative New Diagnostics founded?
Foundation for Innovative New Diagnostics was founded in 2003.
How many portfolio companies does Foundation for Innovative New Diagnostics have?
Foundation for Innovative New Diagnostics has 4 portfolio companies in Caplight's dataset.
What are some companies in Foundation for Innovative New Diagnostics's portfolio?
Portfolio companies visible on Caplight include Cape Bio Pharms, Biomeme, Cape Bio Pharms.
What was Foundation for Innovative New Diagnostics's most recent investment shown here?
Foundation for Innovative New Diagnostics's most recent investment in this portfolio sample was in Biomeme in 2021.
What sectors does Foundation for Innovative New Diagnostics focus on?
Foundation for Innovative New Diagnostics focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Foundation for Innovative New Diagnostics focus on?
Stage focus information for Foundation for Innovative New Diagnostics is not publicly available.